As investors navigate through Q2 earnings season, the broader U.S. market ended sideways, bagging a modest gain of 0.45%, ...

E.l.f. Beauty’s Tarang Amin is rallying staff in their 20s and 30s to grow an affordable beauty brand that’s a hit with teens ...

This week's top media moves include Teen Vogue's new style director, CEO shifts at Converse and Wolford, and more.

Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...

Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand ...

BAND-AID and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...